Saturday 25 February 2017

Pharmacology MCQS-2 For NIPER Exam 2017

1

ANTIARRYTHMIC THAT IS PRIMARILY INDICATED FOR TREATMENT OF SUPRA VENTRICULAR TACHYARRYTHMIAS
A.MEXILETINE   
B. DILITAZEM   
C.NIFEDIPINE   
D. PROPRANOLOL
2

ANTIVIRAL AGENTS EXHIBIT THE GREATEST SELECTIVE TOXICITY FOR THE INVADING VIRUS
A.AMANTADINE   
B.ZIDOVUDINE    
C.IDOXURIDINE    
D.ACYCLOVIR
3

THE DRUG THAT OFTEN CAUSES TACHYCARDIA WHEN GIVEN IN REGULAR DOSES
A.VERAPAMIL  
B.GUANNETHIDINE   
C.PROPRANOLOL    
D.ISOSORBIDE DINITRATE
4

PURPOSE OF A COMBINED DRUG REGIMEN IN TUBERCLOSIS IS TO
     A.      TO DELAY THE EMERGENCE OF DRUG RESISTANCE
     B.       REDUCE THE DURATION OF ACTIVE THERAPY
     C.      SCHEDULE THE ONSET OF THERAPY
     D.      PROMOTE A PLACEBO EFFECT ON THE PATIENT
5

SELECTIVE SEROTONIN REUPTAKE INHIBITOR
A.DESIPRAMINE    
B. FLUOXETINE    
C.BUPROPIONE   
D.MAPROTILINE
6
   
PLASMODIAL RESISTANCE OF CHLOROQUINE IS DUE TO
     A.      INDUCTION OF INACTIVATING ENZYMES
     B.       CHANGE IN RECEPTOR STRUCTURES
     C.      C.INCREASED IN THE ACTIVITY OF DNA REPAIR MECHANISM
     D.      DECREASED CARRIER MEDIATED DRUG TRANSPORT
7

ACTIONS OF OPOID ANALGESICS IS MEDIATED VIA KAPPA RECEPTORS
     A.      CEREBRAL VASCULAR DILATION
     B.      EUPHORIA   
     C.SPINAL ANALGESIA    
     D. PHYSICAL DEPENDENCE
8

ONE OF THE FOLLOWING DRUG HAS ACTIVITY AGAINST HERPES SIMPLEX VIRUS TYPE I AND IS USED TOPICALLY. SYSTEMIC ADMINISTRATION OF THE SAME RESULTS IN BONE MARROW DEPRESSION, HEPATIC DYSFUNCTION AND NEPHROTOXICITY
A.ACYCLOVIR   
B. AMANTADINE    
C.VIDARABINE    
d.IDOXURIDINE
9
DRUG COMBINATION WARFARIN/VITAMIN K RESULTS IN SPECIFIC INTERACTION
A.ANTAGONISTIC     
B.INCREASED SEDATION   
C.NO INTERACTION   
D. HARMFUL IN PRESENCE OF OXIDIZING AGENTS
10

MECHANISM OF DIGITALIS IS
     A.      DECREASED INTRA CELLULAR Na CONCENTRATION
     B.      INHIBITS Na-K ATPase
     C.      ACTIVATED ADENYL CYCLASE WHICH PRODUCES c-AMP
     D.      DECREASED RELEASE OF CALCIUM FROM SARCOPLASMIC RETICULUM

Answers:1.b       2.d     3.b    4.b     5.b      6.d      7.c     8.d     9.a     10.b

No comments:

Post a Comment